Nucleus Group
Nucleus Group, headquartered in the United States, is a leading player in the life sciences industry, specialising in clinical development and regulatory consulting. Founded in 2003, the company has established a strong presence across North America and Europe, providing innovative solutions that streamline the drug development process. Nucleus Group offers a range of core services, including clinical trial management, regulatory affairs, and strategic consulting, distinguished by their commitment to quality and client-centric approach. With a focus on enhancing operational efficiency, the company has achieved notable milestones, including successful collaborations with major pharmaceutical firms. Recognised for its expertise and reliability, Nucleus Group continues to solidify its market position, making significant contributions to the advancement of healthcare solutions worldwide.
DitchCarbon Score
How does Nucleus Group's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nucleus Group's score of 13 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nucleus Group's reported carbon emissions
In 2023, Nucleus Group reported total carbon emissions of approximately 6,238,000 kg CO2e, with emissions distributed across various scopes. Specifically, Scope 1 emissions were about 24,000 kg CO2e, while Scope 2 emissions totalled approximately 106,000 kg CO2e. The majority of their emissions stemmed from Scope 3, which accounted for around 6,108,000 kg CO2e. This includes significant contributions from purchased goods and services (approximately 4,740,000 kg CO2e), employee commuting (about 905,000 kg CO2e), and business travel (approximately 447,000 kg CO2e). In the previous year, 2022, Nucleus Group's emissions were lower, totalling around 4,144,000 kg CO2e in Scope 3, with Scope 1 and 2 emissions at approximately 17,000 kg CO2e and 48,000 kg CO2e, respectively. This indicates a notable increase in emissions from 2022 to 2023, particularly in Scope 3 emissions. Despite the increase in emissions, Nucleus Group has not disclosed specific reduction targets or initiatives aimed at mitigating their carbon footprint. The absence of documented reduction targets suggests a need for further commitment to climate action within the organisation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 17,000 | 00,000 |
| Scope 2 | 48,000 | 000,000 |
| Scope 3 | 4,144,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nucleus Group is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
